These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11372000)

  • 61. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
    Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.
    Sandström R; Knutson TW; Knutson L; Jansson B; Lennernäs H
    Br J Clin Pharmacol; 1999 Aug; 48(2):180-9. PubMed ID: 10417494
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
    Gupta SK; Atkinson L; Tu T; Longstreth JA
    Br J Clin Pharmacol; 1995 Oct; 40(4):325-31. PubMed ID: 8554934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
    Abernethy DR; Wainer IW; Longstreth JA; Andrawis NS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):904-11. PubMed ID: 8355215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemodynamic effect of intravenous verapamil in controlled atrial fibrillation.
    Sloman G; Spokes J; Ramshaw J; Vohra J
    Aust N Z J Med; 1975 Oct; 5(5):420-3. PubMed ID: 1061542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
    Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
    BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of age and gender on the stereoselective pharmacokinetics of verapamil.
    Sasaki M; Tateishi T; Ebihara A
    Clin Pharmacol Ther; 1993 Sep; 54(3):278-85. PubMed ID: 8375122
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
    Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
    Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Atrial fibrillation successfully converted. A new standard in the prevention of recurrence?].
    Fetsch T
    MMW Fortschr Med; 2001 Dec; 143(51-52):10-2. PubMed ID: 11824159
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction.
    Bonaduce D; Petretta M; Ianniciello A; Apicella C; Cavallaro V; Marciano F
    Am J Cardiol; 1997 Mar; 79(5):564-9. PubMed ID: 9068509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetic behavior and tissue distribution of verapamil and its enantiomers in rats by HPLC.
    He L; Wang S
    Arch Pharm Res; 2003 Sep; 26(9):763-7. PubMed ID: 14560927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
    Jin Y; Wang YH; Miao J; Li L; Kovacs RJ; Marunde R; Hamman MA; Philips S; Hilligoss J; Hall SD
    Clin Pharmacol Ther; 2007 Nov; 82(5):579-85. PubMed ID: 17443134
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical use of oral verapamil in chronic and paroxysmal atrial fibrillation.
    Stern EH; Pitchon R; King BD; Guerrero J; Schneider RR; Wiener I
    Chest; 1982 Mar; 81(3):308-11. PubMed ID: 7056105
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    J Pharm Biomed Anal; 2007 Dec; 45(5):762-8. PubMed ID: 17981422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.
    Fuenmayor NT; Faggin BM; Cubeddu LX
    Drugs; 1992; 44 Suppl 1():1-11. PubMed ID: 1283570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.